Physician profile
Samip Morker
NPI 1790914828
$2,290.19
in general payments reported to CMS, 2019-2025
20 companies · $781 in 2025
The $781 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $135 · 2021: $320 · 2022: $222 · 2023: $366 · 2024: $121 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $563.62 | 2021-2025 | Inceptiv, Accurian |
| Abbvie INC. | $339.82 | 2022-2025 | |
| Stryker Corporation | $242.75 | 2019-2023 | Everest Spinal System, Spinejack |
| Medtronic USA, INC. | $220.45 | 2019 | |
| Boston Scientific Corporation | $201.51 | 2025 | Wavewriter Alpha Prime 16 |
| Avanos Medical | $160.37 | 2019-2025 | Genvisc 850 Sodium Hyaluronate |
| Abbott Laboratories | $135.83 | 2020-2025 | Eterna |
| Terumo Bct, INC. | $103.37 | 2022 | |
| Nalu Medical, INC. | $56.38 | 2025 | Nalu Neurostimulation System |
| Allergan, INC. | $52.42 | 2021 | |
| Stratus Medical, LLC | $31.66 | 2021-2023 | Nimbus |
| Scilex Pharmaceuticals INC. | $31.02 | 2024-2025 | |
| Averitas Pharma INC. | $24.19 | 2024 | Qutenza |
| Spr Therapeutics, INC | $22.09 | 2024 | Sprint Pns System |
| Grt US Holding, INC. | $21.95 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $20.14 | 2025 | |
| Collegium Pharmaceutical, INC. | $17.71 | 2025 | Belbuca |
| Curonix LLC | $17.58 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Deroyal Industries, INC. | $15.00 | 2022 | |
| Si-Bone, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samip Morker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.